Skip to content

Opening book details…

About this Medicine article

The Use of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Treatment Management of Bevacizumab and Irinotecan in Patients with Recurrent High-Grade Glioma: A Cost-Effectiveness Analysis by Heinzel, A.; Muller, D.; Langen, K.-J.; Blaum, M.; Verburg, F. A.; Mottaghy, F. M.; Galldiks, N. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Heinzel, A.; Muller, D.; Langen, K.-J.; Blaum, M.; Verburg, F. A.; Mottaghy, F. M.; Galldiks, N.
Publisher
The Society of Nuclear Medicine; Society of Nuclear Medicine; Society of Nuclear Medicine, Inc. (ISSN 0161-5505)
Published
2013
Language
EN
Field
Medicine (Health Sciences)

More by Heinzel, A.; Muller, D.; Langen, K.-J.; Blaum, M.; Verburg, F. A.; Mottaghy, F. M.; Galldiks, N.

Browse all works by Heinzel, A.; Muller, D.; Langen, K.-J.; Blaum, M.; Verburg, F. A.; Mottaghy, F. M.; Galldiks, N.